Sfoglia per Autore

opzioni
Mostrati risultati da 1 a 14 di 14
Titolo Data di pubblicazione Autore(i) File
Role of combined [68Ga]Ga-DOTA-SST analogues and [18F]FDG PET/CT in the management of GEP-NENs. a systematic review 1-gen-2019 Carideo, Luciano; Prosperi, Daniela; Panzuto, Francesco; Magi, Ludovica; Pratesi, Maria Sole; Rinzivillo, Maria; Annibale, Bruno; Signore, Alberto
Multidisciplinary management of neuroendocrine neoplasia: a real-world experience from a referral center 1-gen-2019 Magi, Ludovica; Mazzuca, Federica; Rinzivillo, Maria; Arrivi, Giulia; Pilozzi, Emanuela; Prosperi, Daniela; Iannicelli, Elsa; Mercantini, Paolo; Rossi, Michele; Pizzichini, Patrizia; Laghi, Andrea; Signore, Alberto; Marchetti, Paolo; Annibale, Bruno; Panzuto, Francesco
[18F]FDG-PET/CT and long-term responses to everolimus in advanced neuroendocrine neoplasia 1-gen-2020 Rinzivillo, M.; Prosperi, D.; Mazzuca, F.; Magi, L.; Iannicelli, E.; Pilozzi, E.; Franchi, G.; Laghi, A.; Annibale, B.; Signore, A.; Panzuto, F.
Occurrence of exocrine pancreatic insufficiency in patients with advanced neuroendocrine tumors treated with somatostatin analogs 1-gen-2020 Rinzivillo, M.; De Felice, I.; Magi, L.; Annibale, B.; Panzuto, F.
CT texture analysis of liver metastases in PNETs versus NPNETs. correlation with histopathological findings 1-gen-2020 Martini, I.; Polici, M.; Zerunian, M.; Panzuto, F.; Rinzivillo, M.; Landolfi, F.; Magi, L.; Caruso, D.; Eid, M.; Annibale, B.; Laghi, A.; Iannicelli, E.
[18F]FDG-PET/CT and long-term response to everolimus in advanced neuroendocrine neoplasia 1-gen-2020 Rinzivillo, M; Prosperi, D; Mazzuca, F; Magi, L; Iannicelli, E; Pilozzi, E; Franchi, G; Silveri, Gg; Laghi, A; Annibale, B; Signore, A; Panzuto, F
Comparison of Endoscopic Techniques in the Management of Type I Gastric Neuroendocrine Neoplasia. A Systematic Review 1-gen-2021 Panzuto, Francesco; Magi, Ludovica; Esposito, Gianluca; Rinzivillo, Maria; Annibale, Bruno
Tumor heterogenity in gastro-entero-pancreatic neuroendocrine neoplasia 1-gen-2021 Magi, Ludovica; Rinzivillo, Maria; Panzuto, Francesco
Exocrine pancreatic insufficiency and somatostatin analogs in patients with neuroendocrine neoplasia 1-gen-2021 Panzuto, F.; Magi, L.; Rinzivillo, M.
Reply to Dr. Hall and coworkers 1-gen-2021 Panzuto, F.; Magi, L.; Rinzivillo, M.
Octreotide long-acting release (LAR) in combination with other therapies for treatment of neuroendocrine neoplasia. A systematic review 1-gen-2021 Rinzivillo, M.; de Felice, I.; Magi, L.; Annibale, B.; Panzuto, F.
Efficacy of lutetium-peptide receptor radionuclide therapy in inducing prolonged tumour regression in small-bowel veuroendocrine tumours. A case of favourable response to retreatment after Initial objective response 1-gen-2021 Rinzivillo, M.; Prosperi, D.; Bartolomei, M.; Panareo, S.; Iannicelli, E.; Magi, L.; Panzuto, F.
Role of [18F]FDG PET/CT in the management of G1 gastro-entero-pancreatic neuroendocrine tumors 1-gen-2022 Magi, Ludovica; Prosperi, Daniela; Lamberti, Giuseppe; Marasco, Matteo; Ambrosini, Valentina; Rinzivillo, Maria; Campana, Davide; Gentiloni, Guido; Annibale, Bruno; Signore, Alberto; Panzuto, Francesco
CT-based radiomics for prediction of therapeutic response to Everolimus in metastatic neuroendocrine tumors 1-gen-2022 Caruso, Damiano; Polici, Michela; Rinzivillo, Maria; Zerunian, Marta; Nacci, Ilaria; Marasco, Matteo; Magi, Ludovica; Tarallo, Mariarita; Gargiulo, Simona; Iannicelli, Elsa; Annibale, Bruno; Laghi, Andrea; Panzuto, Francesco
Mostrati risultati da 1 a 14 di 14
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile